Insiders · Profile

Manor Moshe

President & CEO at Protalix BioTherapeutics. Filing since 16 May 2017. CIK 0001623532

Company

Date

Role

Action

Shares

Amount

Of holding

PLX Protalix BioTherapeutics, Inc.

16 May 2017

President & CEO

Bought

50,000

$40.50K

opened

1 decision on file.